StreetInsider.com News Articles

Form 8-K CUMBERLAND PHARMACEUTICA For: Jul 13

Mon, 13 Jul 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260713/26763301.html

Form 8-K CUMBERLAND PHARMACEUTICA For: Jul 13

Mon, 13 Jul 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260713/26763301.html

Cumberland Pharmaceuticals declares $1.50 special dividend after Apotex deal

Mon, 13 Jul 2026 11:00:24 -0400

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) has declared a special cash dividend of $1.50 per share of common stock, payable July 31, 2026, to shareholders of record as of July 10, 2026.

The dividend follows the company's previously announced transaction with Apotex Health, in which Cumberland received $100 million in cash for its line of FDA-approved products. Cumberland also expects to receive up to $11 million in additional payments tied to product inventory and transitional support services.

According to the company, analysis by its tax advisors and updated financial projections indicated greater net cash from the transaction than originally expected, prompting the board

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

NASHVILLE, Tenn., July 13, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), an innovation-focused biopharmaceutical company developing new products for rare diseases, announced today that its Board of Directors has authorized and declared a special cash dividend of $1.50 per share of the Company's common stock. The dividend will be payable on July 31, 2026, to the shareholders of record at the close of business on July 10, 2026.

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Mon, 13 Jul 2026 10:46:00 -0400

Record Date is July 10, 2026 & Payment Date is July 31,2026

Corporate and Insider Share Purchase Initiatives to Continue

Cumberland previously announced

Form 8-K CUMBERLAND PHARMACEUTICA For: Jun 29

Wed, 01 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260701/26720880.html

Form 8-K CUMBERLAND PHARMACEUTICA For: Jun 29

Wed, 01 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260701/26720880.html

Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M

Wed, 01 Jul 2026 09:02:29 -0400

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) has closed a $100 million transaction with a subsidiary of Apotex Health Corp. (APTX.TO), under which Apotex acquired Cumberland's line of branded pharmaceuticals, according to a press release dated July 1, 2026.

The deal received approval from Cumberland shareholders, with over 99% of votes cast in favor. The $100 million cash consideration was funded at closing.

Following the transaction, Cumberland, headquartered in Nashville, Tennessee, will retain its portfolio of product candidates and its majority ownership in Cumberland Emerging Technologies Inc. The company said it will redirect resources toward developing ifetroban, a thromboxane antagonist being studied in four

Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M

Wed, 01 Jul 2026 09:02:29 -0400

The deal received approval from Cumberland shareholders, with over 99% of votes cast in favor. The $100 million cash consideration was funded at closing.

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex

Wed, 01 Jul 2026 09:00:00 -0400